Cargando…

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease

INTRODUCTION: The prevalence of type 2 diabetes mellitus (T2DM) is higher in peripheral artery disease (PAD) than in coronary artery disease (CAD) patients, and PAD overall confers higher cardiovascular risk than CAD. How cardiovascular risk compares between PAD and CAD patients when analyses are st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprenger, Lukas, Mader, Arthur, Larcher, Barbara, Mächler, Maximilian, Vonbank, Alexander, Zanolin-Purin, Daniela, Leiherer, Andreas, Muendlein, Axel, Drexel, Heinz, Saely, Christoph H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593703/
https://www.ncbi.nlm.nih.gov/pubmed/34782334
http://dx.doi.org/10.1136/bmjdrc-2021-002407
_version_ 1784599808689831936
author Sprenger, Lukas
Mader, Arthur
Larcher, Barbara
Mächler, Maximilian
Vonbank, Alexander
Zanolin-Purin, Daniela
Leiherer, Andreas
Muendlein, Axel
Drexel, Heinz
Saely, Christoph H
author_facet Sprenger, Lukas
Mader, Arthur
Larcher, Barbara
Mächler, Maximilian
Vonbank, Alexander
Zanolin-Purin, Daniela
Leiherer, Andreas
Muendlein, Axel
Drexel, Heinz
Saely, Christoph H
author_sort Sprenger, Lukas
collection PubMed
description INTRODUCTION: The prevalence of type 2 diabetes mellitus (T2DM) is higher in peripheral artery disease (PAD) than in coronary artery disease (CAD) patients, and PAD overall confers higher cardiovascular risk than CAD. How cardiovascular risk compares between PAD and CAD patients when analyses are stratified by the presence of type 2 diabetes is unclear and is addressed in the present study. RESEARCH DESIGN AND METHODS: We prospectively recorded major cardiovascular events (MACE; ie, cardiovascular death, myocardial infarction or stroke) over 10.0±4.7 years in 923 patients with stable CAD, of whom 26.7% had T2DM and in 292 patients with PAD, of whom 42.1% had T2DM. Four groups were analyzed: CAD patients without diabetes (CAD/T2DM−; n=677), CAD patients with T2DM (CAD/T2DM+; n=246), PAD patients without diabetes (PAD/T2DM−; n=169) and PAD patients with T2DM (PAD/T2DM+; n=123). RESULTS: The event rate for MACE increased over our four investigated groups: it was lowest in CAD/T2DM− patients (2.52 events per 100 person-years). It was significantly higher in CAD/T2DM+ patients (3.96 events per 100 person-years; p<0.001), in PAD/T2DM− patients (3.68 events per 100 person-years; p=0.022), and in PAD/T2DM+ patients (7.10 events per 100 person-years; p<0.001), who in turn were at a higher risk than CAD/T2DM+ or PAD/T2DM− patients (p=0.001 and p<0.001, respectively). Cox regression analysis after multivariate adjustment showed that the presence of T2DM (HR=1.44 (95% CI 1.09 to 1.92); p=0.012) and the presence of PAD versus CAD (HR=1.48 (95% CI 1.15 to 1.91); p=0.002) were mutually independent predictors of cardiovascular events. CONCLUSIONS: In conclusion, our data show that T2DM as well as the presence of PAD versus CAD are mutually independent predictors of MACE. Patients with both PAD and T2DM are at an exceedingly high risk of cardiovascular events.
format Online
Article
Text
id pubmed-8593703
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85937032021-11-24 Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease Sprenger, Lukas Mader, Arthur Larcher, Barbara Mächler, Maximilian Vonbank, Alexander Zanolin-Purin, Daniela Leiherer, Andreas Muendlein, Axel Drexel, Heinz Saely, Christoph H BMJ Open Diabetes Res Care Cardiovascular and Metabolic Risk INTRODUCTION: The prevalence of type 2 diabetes mellitus (T2DM) is higher in peripheral artery disease (PAD) than in coronary artery disease (CAD) patients, and PAD overall confers higher cardiovascular risk than CAD. How cardiovascular risk compares between PAD and CAD patients when analyses are stratified by the presence of type 2 diabetes is unclear and is addressed in the present study. RESEARCH DESIGN AND METHODS: We prospectively recorded major cardiovascular events (MACE; ie, cardiovascular death, myocardial infarction or stroke) over 10.0±4.7 years in 923 patients with stable CAD, of whom 26.7% had T2DM and in 292 patients with PAD, of whom 42.1% had T2DM. Four groups were analyzed: CAD patients without diabetes (CAD/T2DM−; n=677), CAD patients with T2DM (CAD/T2DM+; n=246), PAD patients without diabetes (PAD/T2DM−; n=169) and PAD patients with T2DM (PAD/T2DM+; n=123). RESULTS: The event rate for MACE increased over our four investigated groups: it was lowest in CAD/T2DM− patients (2.52 events per 100 person-years). It was significantly higher in CAD/T2DM+ patients (3.96 events per 100 person-years; p<0.001), in PAD/T2DM− patients (3.68 events per 100 person-years; p=0.022), and in PAD/T2DM+ patients (7.10 events per 100 person-years; p<0.001), who in turn were at a higher risk than CAD/T2DM+ or PAD/T2DM− patients (p=0.001 and p<0.001, respectively). Cox regression analysis after multivariate adjustment showed that the presence of T2DM (HR=1.44 (95% CI 1.09 to 1.92); p=0.012) and the presence of PAD versus CAD (HR=1.48 (95% CI 1.15 to 1.91); p=0.002) were mutually independent predictors of cardiovascular events. CONCLUSIONS: In conclusion, our data show that T2DM as well as the presence of PAD versus CAD are mutually independent predictors of MACE. Patients with both PAD and T2DM are at an exceedingly high risk of cardiovascular events. BMJ Publishing Group 2021-11-15 /pmc/articles/PMC8593703/ /pubmed/34782334 http://dx.doi.org/10.1136/bmjdrc-2021-002407 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Cardiovascular and Metabolic Risk
Sprenger, Lukas
Mader, Arthur
Larcher, Barbara
Mächler, Maximilian
Vonbank, Alexander
Zanolin-Purin, Daniela
Leiherer, Andreas
Muendlein, Axel
Drexel, Heinz
Saely, Christoph H
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title_full Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title_fullStr Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title_full_unstemmed Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title_short Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
title_sort type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593703/
https://www.ncbi.nlm.nih.gov/pubmed/34782334
http://dx.doi.org/10.1136/bmjdrc-2021-002407
work_keys_str_mv AT sprengerlukas type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT maderarthur type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT larcherbarbara type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT machlermaximilian type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT vonbankalexander type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT zanolinpurindaniela type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT leihererandreas type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT muendleinaxel type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT drexelheinz type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease
AT saelychristophh type2diabetesandtheriskofcardiovasculareventsinperipheralarterydiseaseversuscoronaryarterydisease